This information is intended for US healthcare professionals.

A cell wearing a mask.

CD47 OVEREXPRESSION:

HOW CANCER CONCEALS ITSELF1

Could blocking CD47 unmask cancer and enhance antitumor immunity?1,2

Learn more

View ongoing research on the CD47 immune checkpoint

Watch more videos
Watch more videos here

Uncover the potential role of CD47 overexpression in cancer

Learn about CD47 in myeloid malignancies See the potential impact of CD47 signaling Read about the urgent need and recent developments in myeloid malignancies Sign up to receive updates Download resources about CD47 and more

CD47, cluster of differentiation 47.

References: 1. Chao MP, Takimoto CH, Feng DD, et al. Front Oncol. 2020;9:1380. doi:10.3389/fonc.2019.01380 2. van Duijn A, Van der Burg SH, Scheeren FA. J Immunother Cancer. 2022;10(7):e004589. doi:10.1136/jitc-2022-004589

Gilead Oncology logo in white text. Gilead Oncology logo in white text.

GILEAD and the GILEAD Logo are trademarks of Gilead Sciences, Inc.
© 2023 Gilead Sciences, Inc. All rights reserved. US-UNBP-2023 08/23